36.85
price up icon0.03%   0.010
after-market Dopo l'orario di chiusura: 36.85
loading
Precedente Chiudi:
$36.84
Aprire:
$36.92
Volume 24 ore:
2.01M
Relative Volume:
0.54
Capitalizzazione di mercato:
$15.93B
Reddito:
$2.31B
Utile/perdita netta:
$1.66B
Rapporto P/E:
16.04
EPS:
2.297
Flusso di cassa netto:
$827.02M
1 W Prestazione:
+1.40%
1M Prestazione:
+1.68%
6M Prestazione:
+16.28%
1 anno Prestazione:
+34.69%
Intervallo 1D:
Value
$36.69
$37.16
Intervallo di 1 settimana:
Value
$36.11
$37.69
Portata 52W:
Value
$24.05
$38.00

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
Nome
Royalty Pharma Plc
Name
Telefono
(212) 883-0200
Name
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Name
Dipendente
99
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-11
Name
Ultimi documenti SEC
Name
RPRX's Discussions on Twitter

Confronta RPRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
36.85 16.20B 2.31B 1.66B 827.02M 2.297
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-30 Iniziato Goldman Buy
2025-05-16 Iniziato Morgan Stanley Overweight
2024-06-03 Downgrade UBS Buy → Neutral
2022-06-14 Ripresa UBS Buy
2022-05-13 Iniziato Scotiabank Sector Outperform
2022-04-27 Iniziato Goldman Buy
2022-04-14 Aggiornamento JP Morgan Neutral → Overweight
2022-04-06 Ripresa Morgan Stanley Overweight
2021-10-29 Aggiornamento Citigroup Neutral → Buy
2021-07-30 Iniziato Tigress Financial Buy
2020-11-09 Aggiornamento UBS Neutral → Buy
2020-07-14 Iniziato Evercore ISI In-line
2020-07-13 Iniziato BofA Securities Buy
2020-07-13 Iniziato Citigroup Neutral
2020-07-13 Iniziato Cowen Outperform
2020-07-13 Iniziato Goldman Neutral
2020-07-13 Iniziato JP Morgan Neutral
2020-07-13 Iniziato Morgan Stanley Equal-Weight
2020-07-13 Iniziato SunTrust Buy
2020-07-13 Iniziato UBS Neutral
Mostra tutto

Royalty Pharma Plc Borsa (RPRX) Ultime notizie

pulisher
Oct 23, 2025

Can Royalty Pharma plc stock beat analyst upgradesAnalyst Upgrade & Weekly High Return Forecasts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Royalty Pharma plc reversing from oversold territoryWatch List & Safe Entry Point Identification - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Does Royalty Pharma plc qualify in momentum factor screeningEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Cullen Frost Bankers Inc. Increases Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Royalty Pharma PLC $RPRX Shares Purchased by Cookson Peirce & Co. Inc. - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

What’s the recovery path for long term holders of Royalty Pharma plcEarnings Trend Report & Low Risk Entry Point Tips - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Detecting support and resistance levels for Royalty Pharma plcMarket Performance Report & Daily Entry Point Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What indicators show strength in Royalty Pharma plcShort Setup & Real-Time Volume Analysis Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Allspring Global Investments Holdings LLC Has $881,000 Stake in Royalty Pharma PLC $RPRX - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Using Python tools to backtest Royalty Pharma plc strategies2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Why retail investors pile into Royalty Pharma plc stockEarnings Recap Report & Smart Money Movement Tracker - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

What analysts say about Royalty Pharma plc RPD stockDividend Stability Analysis & Free Transform Portfolio With Stocks - earlytimes.in

Oct 22, 2025
pulisher
Oct 22, 2025

Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

What the charts say about Royalty Pharma plc todayJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What analysts say about Royalty Pharma plc stockEmerging Market Stocks & Subscribe for Free Weekly Winners - earlytimes.in

Oct 21, 2025
pulisher
Oct 21, 2025

Royalty Pharma PLC $RPRX Shares Bought by TD Asset Management Inc - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Is Royalty Pharma plc (RPD) stock a buy during volatile markets2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Is Royalty Pharma plc (RPD) stock undervalued historicallyWeekly Trading Summary & Verified Technical Trade Signals - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Is this a good reentry point in Royalty Pharma plcWeekly Stock Recap & Stepwise Trade Signal Guides - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What candlestick patterns are forming on Royalty Pharma plcWeekly Gains Report & Smart Money Movement Tracker - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Price-Driven Insight from (RPRX) for Rule-Based Strategy - news.stocktradersdaily.com

Oct 20, 2025
pulisher
Oct 20, 2025

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Royalty Landscape - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 19, 2025

Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - sharewise.com

Oct 19, 2025
pulisher
Oct 19, 2025

Nordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 19, 2025
pulisher
Oct 18, 2025

Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22 - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

Is Royalty Pharma plc (RPD) stock bottoming after sell offEarnings Risk Summary & Stepwise Swing Trade Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How strong is Royalty Pharma plc stock revenue growth2025 Key Lessons & Proven Capital Preservation Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Market Moves: How strong is Royalty Pharma plc stock revenue growthTake Profit & Precise Buy Zone Identification - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Royalty Pharma plc stock benefit from upcoming earnings reports2025 EndofYear Setup & Consistent Return Strategy Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Trading Recap: Is Royalty Pharma plc (RPD) stock positioned for secular growth2025 Technical Overview & Fast Exit and Entry Strategy Plans - nchmf.gov.vn

Oct 17, 2025

Royalty Pharma Plc Azioni (RPRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
Capitalizzazione:     |  Volume (24 ore):